Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000932440-06-000294
Filing Date
2006-06-26
Accepted
2006-06-26 16:46:13
Documents
3
Group Members
RIDGEBACK CAPITAL INVESTMENTS LTD.RIDGEBACK CAPITAL MANAGEMENT LLCWAYNE HOLMAN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sch13g_1104097v2.txt SC 13G 17054
2 EXHIBIT 99.1 ex99-1_1104122.txt EX-99.I 2037
3 POWER OF ATTORNEY ex24_1104127.txt EX-24 3424
  Complete submission text file 0000932440-06-000294.txt   24695
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-37954 | Film No.: 06924950
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 430 PARK AVENUE 12TH FLOOR NEW YORK NY 10022
Business Address 430 PARK AVENUE 12TH FLOOR NEW YORK NY 10022 212-624-2567
Ridgeback Capital Investments Ltd. (Filed by) CIK: 0001358916 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G